| Bioactivity | Rovadicitinib is a Janus kinase (JAK) inhibitor with an IC50 value <20 nM. Rovadicitinib also exhibits anti-inflammatory activity[1][2]. |
| Name | Rovadicitinib |
| CAS | 1948242-59-8 |
| Formula | C17H19N7 |
| Molar Mass | 321.38 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Zhu Li, et al. Preparation of pyrrolopyrimidines as Janus kinase inhibitors: Preparation of pyrrolopyrimidines as Janus kinase inhibitors: World Intellectual Property Organization, WO2016095805. 2016-06-23. [3]. WHO Drug Information-World Health Organization (WHO). |